DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ shed 5.36% to $16.61 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 2.24% to 18,680.12 and Dow Jones Industrial Average falling 0.70% to 43,444.99.
This was the stock's second consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed $45.29 below its 52-week high ($61.90), which the company reached on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 1.96% to $5.00, Fortress Biotech Inc. (FBIO) fell 8.92% to $1.43, and Viking Therapeutics Inc. $(VKTX)$ fell 7.45% to $49.58.
Trading volume (296,239) remained 478,212 below its 50-day average volume of 774,451.
Data source: Dow Jones Market Data, FactSet. Data compiled November 15, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 15, 2024 17:24 ET (22:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments